Medicare Rx Must Address “Anger” Over Drug Prices, AARP’s Rother Says
AARP remains convinced that Congress needs to address the high price of prescription drugs
You may also be interested in...
A U.S./Canada pharmaceutical importation system may be inevitable, Roche Global Pharmaceutical Head William Burns suggested during an Oct. 16 investor conference call
AARP is endorsing prescription drug reimportation from Canada as a measure to help control the cost of drugs
The Congressional Budget Office's determination that prescription drug reimportation would not provide any cost savings could help House/Senate Medicare conferees distance themselves from the House's positive vote on reimportation